UC
EW icon

Unio Capital’s Edwards Lifesciences EW Stock Holding History

Unio Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,400
Closed -$344K – 68
2019
Q1 		$344K Hold
5,400
– – 0.24% 48
2018
Q4 		$276K Hold
5,400
– – 0.22% 52
2018
Q3 		$313K Buy
+5,400
New +$264K 0.21% 50
2018
Q2 		– Sell
-6,000
Closed -$280K – 72
2018
Q1 		$279K Hold
6,000
– – 0.23% 59
2017
Q4 		$225K Buy
+6,000
New +$220K 0.19% 77

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Unio Capital's EW Position: Q2 2019 in Review

Unio Capital sold out of Edwards Lifesciences (EW) in Q2 2019, closing a stake of 5,400 shares — an estimated $344K sold.

Unio Capital first reported a position in EW in Q4 2017 and held it in 5 quarters. The position peaked at $344K in Q1 2019. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

  • Unio Capital reported no remaining Edwards Lifesciences position as of Q2 2019 after selling out during the quarter.
  • Unio Capital sold 5,400 Edwards Lifesciences shares in Q2 2019, an estimated $344K.
  • Unio Capital first reported a position in Edwards Lifesciences in Q4 2017 and held it in 5 quarters.
  • Unio Capital's Edwards Lifesciences position peaked at $344K in Q1 2019.
  • 921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on Unio Capital's 13F filing for Q2 2019, filed 14 Aug 2019.